In 2020, a pneumonia epidemic caused by a new coronavirus affects the hearts of people across the country. Isolation and disinfection, molecular diagnosis, body temperature monitoring, image diagnosis, respiratory treatment and other necessary medical consumables and equipment have become strategic materials in this epidemic, which directly affects the overall situation of the anti-epidemic situation. Shenzhen New Industry Biomedical Engineering Co., Ltd. developed the world's first chemiluminescence detection reagent for the new crown virus in February, providing a new "ammunition" for the battlefield against "epidemic".
"The test results come out one minute earlier, and there is one minute less risk of infection." Rao Wei, chairman of New Industry Biology said that the chemiluminescence immunoassay method has the advantages of fast detection speed, low requirements for the experimental environment, and high accuracy of the results. The high-throughput chemiluminescence immunoassay platform can produce the first result in 25 minutes. The fastest model can complete 300 test items per hour, which is an effective complement to current CT and nucleic acid detection.
The secret of rapid research and development is to do early combat readiness, expecting the enemy to take the lead. "In mid-January, we were informed of the outbreak of pneumonia in Wuhan. The company immediately organized more than 50 backbones in various departments such as raw material R & D and reagent R & D to carry out emergency research. After fighting day and night, it took only ten days to successfully develop a new type. Coronavirus recombinantly expressed antigens, as well as new coronavirus IgM and IgG antibodies fully automated chemiluminescence immunoassay detection kits. "
It is worth mentioning that the staff of the State Administration of Taxation, Shenzhen Pingshan District Taxation Bureau, contacted Ding Chenliu, the head of new industry biofinance, as soon as he learned about the enterprise, to publicize a series of taxes to support the prevention and control of the epidemic Preferential policies, arranged policy counselors for enterprises, and opened up green channels for taxation.
"After we saw the three announcements, it was really high morale and confidence. It was really a timely rain. It is still worrying about how to implement the landing on our company as soon as possible." Ding Chenliu said, "I did not expect that the tax staff Contacted us immediately by phone, and conducted detailed policy interpretation and guidance through WeChat. "
According to the Announcement No. 8 of 2020 issued by the Ministry of Finance and the State Administration of Taxation, the outbreak prevention and control key production material enterprises determined by the provincial and above development and reform departments, industry and information technology departments can enjoy newly acquired relevant equipment for one-time enterprise income tax. Preferential policies such as deducting and refunding incremental VAT credits. After grasping the policy situation, New Industrial Bio has started to prepare relevant application materials.
Ding Chenliu said, "We were able to develop the first chemiluminescence detection reagent for neocrown virus in the world. This is because we have always focused on the field of chemiluminescence immunoassay. It is also because we have a strong R & D team. The country has always supported tax policies. In particular, a series of tax and fee reduction policies in 2019 have strongly supported the development and scientific research activities of our enterprises. "For example, after the increase of the deduction ratio for research and development expenses, new industry biotechnology companies throughout the year Income tax reduction and exemption exceeds 9.8 million yuan, in addition, enjoy export tax rebate of about 22.05 million yuan and value-added tax surcharges of about 1.5 million yuan; "After the implementation of the new personal income tax law, our withholding and payment is also from 1508 in 2018 The amount of 10,000 yuan decreased to 7.94 million yuan in 2019, a year-on-year decrease of 47.37%, which greatly helped us attract more high-end scientific research talents. "It is reported that there are more than 1,700 employees in new industry biology, including doctors, masters and More than 200 overseas returnees have professional teams such as reagent R & D and production centers, instrument R & D and manufacturing centers, and marketing centers.
It is understood that the taxation department of Pingshan District will give priority to reviewing and expediting the application of invoices and tax refunds for key anti-epidemic materials production enterprises. Considering that relevant enterprises are devoting themselves to the production of anti-epidemic materials to prevent the epidemic, the department also provides tolerance Acceptance services.
On February 19th, New Industry Bio-tech completed EU access and became the first company in the world to have a CE mark and a chemiluminescence reagent antibody for the new crown virus antibody that was publicly sold in the EU. At present, New Industry Bio has distributed 100,000 reagents for free to Beijing Xiehe Hospital, Wuhan Xiehe Hospital, and the Fifth Medical Center of the General Hospital of the People's Liberation Army. Rao Wei introduced: "Now the company's fully automated production line has started mass production of reagents, which can produce 10,000 boxes per day. Our full-automatic chemiluminescence immunoassay analyzers have installed more than 10,000 units nationwide, basically many prefecture-level cities and above. All the hospitals have corresponding testing equipment. There are more than 400 in Hubei and nearly 100 in Wuhan. A large number of samples can be collected in a short period of time. Once they are verified to be effective, they will be put into production as soon as possible to contribute to winning the new crown pneumonia prevention and control fight. "
Start reading Shenzhen
Reporter Chen Faqing